Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Catalyst Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Catalyst Pharmaceuticals Inc
Rating: 2.0193195
Author: Trendlyne DVM scores

Await Turnaround

about

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Com...

23.23 -0.16 (-0.68%)

1.0M

XNAS Volume

XNAS 13 Mar, 2026 4:01 PM (EDT)

Low Financial Strength

27.8 / 100

Mid Valuation

48.0 / 100

Technically Neutral

58.0 / 100

Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM

1Yr Price target upside is 46%

7 analysts

Catalyst Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Com...

SWOT Analysis

Catalyst Pharma Inc Live Price Chart